MHRI Department of Neuroscience in Mental Health - Research Publications
Now showing items 1-3 of 3
Peripheral alpha-Defensins 1 and 2 are Elevated in Alzheimer's Disease
(IOS PRESS, 2015-01-01)
Biomarkers enabling the preclinical identification of Alzheimer's disease (AD) remain one of the major unmet challenges in the field. The blood cellular fractions offer a viable alternative to current cerebrospinal fluid ...
Do current therapeutic anti-A beta antibodies for Alzheimer's disease engage the target?
Reducing amyloid-β peptide (Aβ) burden at the pre-symptomatic stages of Alzheimer's disease (AD) is currently the advocated clinical strategy for treating this disease. The most developed method for targeting Aβ is the use ...
Anti-A beta antibody target engagement: a response to Siemers et al.